scholarly journals Hemostatic changes associate with mortality in hospitalized patients with HIV-associated tuberculosis: a prospective cohort study

2016 ◽  
pp. jiw532 ◽  
Author(s):  
Saskia Janssen ◽  
Charlotte Schutz ◽  
Amy M. Ward ◽  
Mischa A.M. Huson ◽  
Robert J. Wilkinson ◽  
...  
2011 ◽  
Vol 26 (3) ◽  
pp. 330.e1-330.e8 ◽  
Author(s):  
Suelene Aires Franca ◽  
Carlos Toufen ◽  
André Luiz D. Hovnanian ◽  
André Luís P. Albuquerque ◽  
Eduardo R. Borges ◽  
...  

2018 ◽  
Vol 70 (8) ◽  
pp. 1228-1236 ◽  
Author(s):  
Byung-Gon Na ◽  
Sung-Sik Han ◽  
Yeong-Ah Cho ◽  
Gyung-Ah Wie ◽  
Ji-Yeon Kim ◽  
...  

PLoS Medicine ◽  
2019 ◽  
Vol 16 (7) ◽  
pp. e1002840 ◽  
Author(s):  
Charlotte Schutz ◽  
David Barr ◽  
Bruno B. Andrade ◽  
Muki Shey ◽  
Amy Ward ◽  
...  

2016 ◽  
Vol 35 (1) ◽  
pp. 144-152 ◽  
Author(s):  
Johane P. Allard ◽  
Heather Keller ◽  
Khursheed N. Jeejeebhoy ◽  
Manon Laporte ◽  
Don R. Duerksen ◽  
...  

Author(s):  
Júlia Epping Brito ◽  
Camila Ferri Burgel ◽  
Júlia Lima ◽  
Victória Silva Chites ◽  
Camila Becker Saragiotto ◽  
...  

2021 ◽  
Author(s):  
Alexandre Perez Gonzalez ◽  
Alejandro Araujo-Ameijeiras ◽  
Alberto Fernandez-Villar ◽  
Manuel Crespo ◽  
Eva Poveda

Background. Survivors to COVID-19 have described long-term symptoms after acute disease. These signs constitute a heterogeneous group named long COVID or persistent COVID. Objective: The aim of this study is to describe persisting symptoms six months after COVID-19 diagnosis in a prospective cohort in the Northwest Spain Design. This is a prospective cohort study performed in the COVID-19 Cohort of Galicia Sur Health Institute (COHVID-GS). Participants: This cohort includes patients in clinical follow-up in a health area of 569,534 inhabitants after SARS-CoV-2/COVID-19 diagnosis. Clinical and epidemiological characteristics were collected during the follow up. Main measures and key results. A total of 284 patients completed 6 months follow-up, 176 (69.4%) required hospitalization and 29 (10.2%) of them needed critical care. At six months, 119 (48.0%) patients described one or more persisting symptoms. The most prevalent were: extra-thoracic symptoms (39.1%), chest symptoms (27%), dyspnoea (20.6%), and fatigue (16.1%). These symptoms were more common in hospitalized patients (52.3% vs 38.2%) and in women (59.0% vs 40.5%). The multivariate analysis identified Chronic Obstructive Pulmonary Disease (COPD), female gender and tobacco consumption as risk factors for long COVID. Conclusions. Persisting symptoms are common after COVID-19 especially in hospitalized patients compared to outpatients (52.3% vs. 38.2%). Based on these findings, special attention and clinical follow-up after acute SARS-CoV-2 infection should be provided for hospitalized patients with previous lung diseases, tobacco consumption, and females.


2021 ◽  
Author(s):  
Alexandre Pérez González ◽  
Alejandro Araújo ◽  
Alberto Fernández-Villar ◽  
Manuel Crespo ◽  
Eva Poveda

Abstract Background. Survivors to COVID-19 have described long-term symptoms after acute disease. These signs constitute a heterogeneous group named long COVID or persistent COVID.Objective: The aim of this study is to describe persisting symptoms six months after COVID-19 diagnosis in a prospective cohort in the Northwest SpainDesign. This is a prospective cohort study performed in the COVID-19 Cohort of Galicia Sur Health Institute (COHVID-GS). Participants: This cohort includes patients in clinical follow-up in a health area of 569,534 inhabitants after SARS-CoV-2/COVID-19 diagnosis. Clinical and epidemiological characteristics were collected during the follow up.Main measures and key results. A total of 284 patients completed 6 months follow-up, 176 (69.4%) required hospitalization and 29 (10.2%) of them needed critical care. At six months, 119 (48.0%) patients described one or more persisting symptoms. The most prevalent were: extra-thoracic symptoms (39.1%), chest symptoms (27%), dyspnoea (20.6%), and fatigue (16.1%). These symptoms were more common in hospitalized patients (52.3% vs 38.2%) and in women (59.0% vs 40.5%). The multivariate analysis identified Chronic Obstructive Pulmonary Disease (COPD), female gender and tobacco consumption as risk factors for long COVID.Conclusions. Persisting symptoms are common after COVID-19 especially in hospitalized patients compared to outpatients (52.3% vs. 38.2%). Based on these findings, special attention and clinical follow-up after acute SARS-CoV-2 infection should be provided for hospitalized patients with previous lung diseases, tobacco consumption, and females.


Sign in / Sign up

Export Citation Format

Share Document